Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5

International Journal of Impotence Research
R H Cote

Abstract

Phosphodiesterase 6 (PDE6) is highly concentrated in the retina. It is most abundant in the internal membranes of retinal photoreceptors, where it reduces cytoplasmic levels of cyclic guanosine monophosphate (cGMP) in rod and cone outer segments in response to light. The rod PDE6 holoenzyme comprises alpha and beta catalytic subunits and two identical inhibitory gamma subunits. Each catalytic subunit contains three distinct globular domains corresponding to the catalytic domain and two GAF domains (responsible for allosteric cGMP binding). The PDE6 catalytic subunits resemble PDE5 in amino-acid sequence as well as in three-dimensional structure of the catalytic dimer; preference for cGMP over cyclic adenosine monophosphate (cAMP) as a substrate; and the ability to bind cGMP at the regulatory GAF domains. Most PDE5 inhibitors inhibit PDE6 with similar potency, and electroretinogram studies show modest effects of PDE5 inhibitors on visual function-an observation potentially important in designing PDE5-specific therapeutic agents.

References

Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·P DeterreM Chabre
May 2, 1997·The Journal of Biological Chemistry·A E GranovskyN O Artemyev
May 15, 1998·The New England Journal of Medicine·I GoldsteinP A Wicker
Aug 26, 1998·The Journal of Biological Chemistry·A M MarzescoA Zahraoui
Sep 12, 1998·The Journal of Biological Chemistry·A E GranovskyN O Artemyev
Apr 29, 2000·The Journal of Biological Chemistry·F HeT G Wensel
Oct 12, 2000·The Journal of Biological Chemistry·A E Granovsky, N O Artemyev
Apr 4, 2001·The Journal of Biological Chemistry·A E Granovsky, N O Artemyev
Jul 17, 2001·Journal of Molecular Biology·J F Kameni TcheudjiP Schultz
Sep 1, 2001·American Journal of Ophthalmology·J K LuuM F Marmor
Dec 14, 2001·The Journal of Biological Chemistry·Michael J PagliaRick H Cote
Jan 12, 2002·The Journal of Biological Chemistry·Vanessa NancyJean de Gunzburg
Feb 5, 2002·Annual Review of Physiology·Vadim Y ArshavskyEdward N Pugh
Sep 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sergio E MartinezJoseph A Beavo
Jan 30, 2003·The EMBO Journal·Sergei D RybalkinJoseph A Beavo

❮ Previous
Next ❯

Citations

Apr 20, 2010·Biochemistry·Zhongming Zhang, Nikolai O Artemyev
Jun 6, 2008·International Journal of Impotence Research·M J Thurtell, R L Tomsak
Jun 2, 2005·The Journal of General Physiology·David Holcman, Juan I Korenbrot
Sep 2, 2009·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Dan LarhammarTomas A Larsson
Oct 29, 2010·Respiratory Research·Sevdalina NikolovaSoni S Pullamsetti
Jan 6, 2009·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Yasuyuki KamataSeiji Minota
Dec 3, 2014·International Journal of Cardiology·Jichun WangHong Jiang
Mar 24, 2015·Journal of Enzyme Inhibition and Medicinal Chemistry·Mariusz MojzychEmilia Fornal
Jul 10, 2012·Expert Opinion on Drug Metabolism & Toxicology·Mohammad Amin RezvanfarMohammad Abdollahi
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Frank Sommer
Oct 14, 2010·Expert Opinion on Investigational Drugs·Ma LiminWayne J G Hellstrom
Jun 12, 2009·Cutaneous and Ocular Toxicology·Chris J SompsGareth Phillips
Nov 19, 2014·Proceedings of the National Academy of Sciences of the United States of America·Gautam SikkaDan E Berkowitz
Jan 12, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Michelle E McClements, Robert E MacLaren
Oct 16, 2007·Drug Discovery Today·Tobias B Halene, Steven J Siegel
Feb 4, 2009·Journal of Neurochemistry·François Paquet-DurandPer Ekström
Mar 28, 2006·Experimental Eye Research·Marcel A Ionita, Steven J Pittler
Mar 8, 2006·Neurochemistry International·Agnes SimonJulianna Kardos
Apr 12, 2016·Frontiers in Immunology·Verena Katharina RakerKerstin Steinbrink
Apr 23, 2014·Fundamental & Clinical Pharmacology·Carolina OteroJuan E Jung
Jan 18, 2012·The Biochemical Journal·Dakshnamurthy SelvakumarDennis G Drescher
May 17, 2015·Endocrine-related Cancer·Rodrigo B de AlexandreFabio R Faucz
Nov 1, 2005·Vision Research·Hakim MuradovNikolai O Artemyev
Sep 23, 2014·Experimental Eye Research·Lisa Nivison-SmithMichael Kalloniatis
Nov 5, 2013·Journal of Chemical Information and Modeling·Yi-You HuangHai-Bin Luo
Jan 16, 2015·PloS One·Ninthujah KanageswaranGünter Gisselmann
Apr 14, 2017·Journal of Medicinal Chemistry·Brian DyckAli Tabatabaei
Jan 8, 2017·Molecular Neurobiology·Dominic Ngima Nthenge-Ngumbau, Kochupurackal P Mohanakumar
Aug 29, 2018·Ophthalmic Genetics·Vitor K L TakahashiStephen H Tsang
Feb 20, 2007·Circulation Research·Kenji Omori, Jun Kotera
Jun 29, 2012·Korean journal of urology·Hyun Hwan Sung, Sung Won Lee
Oct 5, 2018·JAMA Ophthalmology·Sasha Matthew RosenFelipe De Alba
Jun 17, 2008·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Takafumi YamaguchiTakeshi Imaoka
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alan M Laties

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.